These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26018720)

  • 1. Pituitary 18F-FDG Uptake Correlates With Serum TSH Levels in Subjects With Diffuse Thyroid 18F-FDG Uptake.
    Jeong YH; Kim D; Lee JW; Rhee Y; Nam KH; Yun M; Kim CK
    Clin Nucl Med; 2015 Aug; 40(8):632-6. PubMed ID: 26018720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary 18F-FDG uptake correlates with serum TSH levels in thyroid cancer patients on 18F-FDG PET/CT.
    Ding Y; Wu S; Xu J; Wang H; Ma C
    Nucl Med Commun; 2019 Jan; 40(1):57-62. PubMed ID: 30422898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse thyroid uptake incidentally found on 18F-fluorodeoxyglucose positron emission tomography in subjects without cancer history.
    Lee JY; Choi JY; Choi YH; Hyun SH; Moon SH; Jang SJ; Choe YS; Lee KH; Kim BT
    Korean J Radiol; 2013; 14(3):501-9. PubMed ID: 23690721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland.
    Karantanis D; Bogsrud TV; Wiseman GA; Mullan BP; Subramaniam RM; Nathan MA; Peller PJ; Bahn RS; Lowe VJ
    J Nucl Med; 2007 Jun; 48(6):896-901. PubMed ID: 17504869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.
    Kurata S; Ishibashi M; Hiromatsu Y; Kaida H; Miyake I; Uchida M; Hayabuchi N
    Ann Nucl Med; 2007 Aug; 21(6):325-30. PubMed ID: 17705011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.
    Eloy JA; Brett EM; Fatterpekar GM; Kostakoglu L; Som PM; Desai SC; Genden EM
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid stimulating hormone levels.
    Pruthi A; Choudhury PS; Gupta M; Taywade S
    Indian J Nucl Med; 2015; 30(1):16-20. PubMed ID: 25589800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma.
    Petrich T; Börner AR; Otto D; Hofmann M; Knapp WH
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):641-7. PubMed ID: 11976802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of TSH on uptake of [18F]fluorodeoxyglucose in human thyroid cells in vitro.
    Deichen JT; Schmidt C; Prante O; Maschauer S; Papadopoulos T; Kuwert T
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):507-12. PubMed ID: 14722674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of CT density in patients with diffusely increased FDG uptake in the thyroid gland on PET/CT images.
    Han YM; Kim YC; Park EK; Choe JG
    AJR Am J Roentgenol; 2010 Jul; 195(1):223-8. PubMed ID: 20566820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of patterns of increased [
    Tsubaki F; Kurata S; Tani J; Sumi A; Fujimoto K; Abe T
    Jpn J Radiol; 2018 Mar; 36(3):181-193. PubMed ID: 29280068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic thyroiditis: diffuse uptake of FDG at PET.
    Yasuda S; Shohtsu A; Ide M; Takagi S; Takahashi W; Suzuki Y; Horiuchi M
    Radiology; 1998 Jun; 207(3):775-8. PubMed ID: 9609903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
    Brindle R; Mullan D; Yap BK; Gandhi A
    Eur J Surg Oncol; 2014 Nov; 40(11):1528-32. PubMed ID: 24915858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
    Nascimento C; Borget I; Al Ghuzlan A; Deandreis D; Hartl D; Lumbroso J; Berdelou A; Lepoutre-Lussey C; Mirghani H; Baudin E; Schlumberger M; Leboulleux S
    Thyroid; 2015 Apr; 25(4):437-44. PubMed ID: 25633259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
    Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
    Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A; Kalinyak JE; McDougall IR
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of patterns of incidental thyroid uptake at (18)F-FDG PET/CT.
    Agrawal K; Weaver J; Ngu R; Krishnamurthy Mohan H
    Clin Radiol; 2015 May; 70(5):536-43. PubMed ID: 25687827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
    Kim BH; Kim SJ; Kim H; Jeon YK; Kim SS; Kim IJ; Kim YK
    Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with the development of new onset diffuse thyroid F18-fluorodeoxyglucose uptake after treatment of breast cancer in patients without a history of thyroid disease or thyroid dysfunction.
    Kim SS; Kim SJ; Bae YT; Lee JY; Kim BH; Kim YK; Kim IJ
    Thyroid; 2012 Jan; 22(1):53-8. PubMed ID: 22142373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.